MedPath

Study on High-sensitivity Troponin 0h/1h for Rapid Diagnosis of Non-ST-segment Elevation Myocardial Infarction in the Chinese Population

Conditions
Non-ST-segment Elevation Myocardial Infarction
Registration Number
NCT03331549
Lead Sponsor
Beijing Anzhen Hospital
Brief Summary

The purpose of the study is to establish a high-sensitivity troponin 0h/1h process for the diagnosis of patients suspected of NSTEMI for the Chinese population, obtain the inclusion and exclusion criteria for diagnosis of these patients and compare the new process with the existing diagnosing methods and processes, including the 3h and 6h processes more extensively used at present and the ECG combined with troponin diagnosis, so as to explore a confirmation model suitable for the Chinese population.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
400
Inclusion Criteria
  1. Patients experiencing acute chest pain or angina pectoris symptom within 12 hours before visiting the hospital;
  2. Or those experiencing acute chest pain or angina pectoris peak within 12 hours before visiting the hospital.
Exclusion Criteria

Patients showing ST-segment elevation during ECG and pregnant women.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Diagnosis of non-ST-segment elevation myocardial infarctionAfter measuring the high-sensitivity troponin level at 1h or 3h
Secondary Outcome Measures
NameTimeMethod
Cardiovascular events or deathFollow-up for 6 months after diagnosis

Trial Locations

Locations (1)

Beijing Anzhen Hospital, Capital Medical University

🇨🇳

Beijing, China

© Copyright 2025. All Rights Reserved by MedPath